Cellandtech Group Expands Its Global Life-Science Consulting to Include Market Access and New Product Planning

Tuesday, October 16, 2018 Drug News
Email Print This Page Comment bookmark
Font : A-A+

Biopharmaceutical and medical device executives band together to offer global services and insights

GAITHERSBURG, Md., Oct. 16, 2018 /PRNewswire-PRWeb/ -- Cellandtech Group, a life-science commercial strategy consulting

firm announced today that it has expanded its global talent pool of biopharmaceutical and medical device consultants to launch two "new" Practice groups – a Global Market Access and Pricing Strategy Practice and a New Product Planning Practice.

"We are excited to expand our portfolio of global life-science advisory services. These new capabilities are underpinned by our global consultants, who are focused on providing customized, client-centric solutions associated with New Product Planning, Market Access, Pricing and Product Strategy," stated Steven M. Walker, Principal at Cellandtech Group. He added, "More than ever development-staged companies are seeking advisory firms as strategic partners; that can provide actionable insights, balanced with first-hand experience creating industry's best practices. Our new practices will help directly address these marketplace needs."

The Cellandtech Group will focus its New Product Planning Practice on clients seeking to minimize financial and competitive risk, as well as internal bias found in their go-to-market strategies. The Market Access and Pricing Strategy Practice will focus more on clients looking to better understand how best to ensure product receptivity amongst patients and payers.

The development process for biopharmaceuticals and medical devices is time-intensive, complex and expensive. Cellandtech Group works with companies to minimize these burdens. Cellandtech Group is headquartered in the mid-Atlantic of the United States but also has a global footprint in Europe and Asia. Cellandtech Group's services are primarily tailored towards manufacturers of biotechnology, pharmaceuticals and medical devices, as well as life-science venture capitalist and small- to mid-size contract research organizations (CROs).

Cellandtech Group is now divided into 3 complimentary life-science advisory practices, with an emphasis on market entry and commercialization disciplines:

  •     Product and Services Strategy,
  •     New Product Planning Strategy
  •     Market Access and Pricing Strategy (US & EU)

About Cellandtech Group (http://www.Cellandtech.com)

The Cellandtech Group is a strategic planning and commercialization consultancy firm. Cellandtech Group provides insight, analysis and strategy to development-stage life science companies, venture capitalists and contract research organizations (CROs) around the world with a focus on product/service strategy, product commercialization, market access and pricing strategy.

The firm understands domestic and international markets, driven by their in-country experts. The Cellandtech Group draws upon the experience of their global team of senior consultants to bring a vast amount of market, disease-state and operational expertise to their clients.

If you would like more information about this topic, please call Steven M. Walker – Principal, Cellandtech Group at 240-207-1234, or email SMWalker(at)Cellandtech(dot)com.


SOURCE Cellandtech Group

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store